With the recent observance of “World Gut Health Day,” concerns about gut health among the Chinese population have once again come to the forefront. Modern lifestyles characterized by irregular eating patterns, high-fat and high-sugar diets, insufficient dietary fiber intake, coupled with significant work-related stress, sedentary behavior, and lack of physical activity, have made individuals more prone to gut-related issues. According to a survey report published by the Wen Wei Po in 2024, over 90% of the Chinese population suffers from gut-related issues. In the eyes of the general public, the gut is merely a digestive organ responsible for breaking down food and absorbing nutrients, with limited functions. However, this is not the case.
In fact, the gut houses over 70% of the body's immune cells, serving as a crucial “immune factory” for the body. It even possesses the ability to regulate emotions, earning it the title of the “second brain.” Many modern diseases, including not only digestive system disorders like diarrhea and enteritis but also imbalances in the gut microbiota, are linked to conditions in other systems such as epilepsy, Parkinson's disease, Alzheimer's disease, depression, autism, ADHD, diabetes, tumors, obesity, and cardiovascular diseases. These conditions all exhibit signs of gut microbiota imbalance. Clinical studies and practical applications have demonstrated that transplanting gut microbiota from healthy individuals into patients can alleviate symptoms of various diseases.
Based on this, the Foresea Yihe International Medical Center has launched a gut microbiota transplantation program aimed at improving gut microbiota and helping restore the gut microbiome to a healthy state. The program will first conduct 16S rDNA gut microbiota testing and other medical examinations to comprehensively assess the structure of gut microbiota, the degree of imbalance, and the risk of disease occurrence, generating a microbiota testing report. Subsequently, the hospital will select and match the most suitable microbiota for the patient from a donor bank provided by young, healthy individuals. The microbiota will be processed using sterile, anaerobic, and contamination-free methods and administered via oral capsules for precise transplantation. After transplantation, the hospital will implement a 21-day regimen of dietary and lifestyle control for the patient and conduct post-transplantation testing to assess the status of the transplanted microbiota. Following this, the hospital will provide three months of health follow-up management for the patient.
This transplantation method differs from oral probiotics, as it involves the overall transplantation of over 1,000 beneficial microorganisms from a healthy human body to restore an imbalanced intestinal environment. In terms of transplantation quantity, restoration, and colonization effects, it far surpasses the latter, potentially offering patients a breakthrough solution to stubborn health challenges.
It is reported that the Foresea Yihe International Medical Center is a high-level comprehensive medical service platform specially established by the Guangzhou General Hospital of Foresea Life Insurance, providing patients with personalized high-quality medical services. Gut microbiota transplantation, as one of its key specialty programs, leverages a leading multidisciplinary expert team and boasts the FMT 3.0 technology advantage, which is internationally leading, holds multiple patents, and has obtained safety certifications.
